Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Healthcare Merger Corp. was a healthcare-focused special purpose acquisition company formed to complete a business combination in the healthcare sector. It completed its IPO in December 2019 and announced a merger with acute care telemedicine provider SOC Telemed in July 2020. On October 30, 2020, the transaction closed and Healthcare Merger Corp. was renamed SOC Telemed, Inc. As a SPAC, Healthcare Merger Corp. did not itself develop therapeutics, maintain a drug pipeline, or operate as a biotech or pharmaceutical R&D company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Healthcare Merger Corp..